Prostatype Genomics Navigation
  • THE PROSTATYPE® TEST SYSTEM
    • Prostate cancer and the prognostic challenge
    • Prostatype – The solution
    • Why Prostatype?
    • Resources
      • Publications and Posters
      • White Paper
      • Technical Documents
    • Legal
    • Visit Prostatype® web site
  • ABOUT US
    • Company in brief
    • Mission and Vision
    • History
    • Board of directors
    • Senior management
    • Corporate group structure
    • Advisory Board
    • Careers
  • PRESS & NEWS
  • INVESTOR RELATIONS
    • Reports and presentations
    • Analyst coverage
    • Financial calendar
    • Share and shareholder information
    • Corporate governance
    • IPO
    • IR contact
    • Certified Adviser
  • Contact
  • THE PROSTATYPE® TEST SYSTEM
    • Prostate cancer and the prognostic challenge
    • Prostatype – The solution
    • Why Prostatype?
    • Resources
      • Publications and Posters
      • White Paper
      • Technical Documents
    • Legal
    • Visit Prostatype® web site
  • ABOUT US
    • Company in brief
    • Mission and Vision
    • History
    • Board of directors
    • Senior management
    • Corporate group structure
    • Advisory Board
    • Careers
  • PRESS & NEWS
  • INVESTOR RELATIONS
    • Reports and presentations
    • Analyst coverage
    • Financial calendar
    • Share and shareholder information
    • Corporate governance
    • IPO
    • IR contact
    • Certified Adviser
  • Contact

THE PROSTATYPE® TEST SYSTEM

How it works
FOR PATIENTS
A DISEASE WITH MANY FACES
THE ROAD TO DIAGNOSIS
THE ROAD TO TREATMENT
TREATMENTS
for clinicians
benefits
advantages
results
quality standards
technical documents
scientific publications
clinical validation
technical videos

Contact

Gustaf III:s Boulevard 34
169 73 Solna
+46 (0)8-20 87 00‬‬
info@prostatypegenomics.com

Prostatype.se

Menu

THE PROSTATYPE® TEST SYSTEM
ABOUT US
PRESS & NEWS
INVESTOR RELATIONS
CONTACT

EIT Health

Subscribe

    Hemsida skapad av Webb & SEO Byrå Hjalmar&Company

    SITEMAP I Privacy Policy

    A Message from Prostatype Genomics AB Regarding COVID-19. In response to the COVID-19 outbreak the World Health Organization (WHO) declared a pandemic on Wednesday 11th March 2020.

    Read more!
    X